Latest Breaking News On - Liangzhi xie - Page 1 : comparemela.com

Developing and manufacturing custom recombinant antibodies for R&D

In this interview, Dr. Linlin Zhang, technical specialist for Sino Biological Europe, discusses how Sino is expanding its product offerings into the European market and outlines its process for developing and manufacturing custom recombinant antibodies for their clients.

United statesUnited kingdomAlex smithLiangzhi xieZhang lin lintechnical specialistsinoLinlin zhangSino biological inc aprSino biological incSponsored contentZhang lin lintechnical specialistsino biologicalSino biological europeSino biologicalNorth americanSino biological europe herCell sortingCovid 19

Adapting biological research and development to COVID-19

In this interview, News-Medical talks to Dr Yuning Chen, about the work he does with Sino Biological and how they have adapted their research & development to the COVID-19 pandemic.

Oasisamuel shutterstockGorodenkoff shutterstockAndrii vodolazhskyiLiangzhi xieYuning chenYuning chenrd managersinoMotorolka shutterstockOhio universitySino biological inc octResearch duringSponsored contentSino biologicalDevelopment managerConvalescent plasmaE coliInfectious diseases

Sino Biological Announces Successful Closing of 4 98 Billion RMB Public Offering and Listing on the Shenzhen ChiNext Stock Exchange

Sino Biological Announces Successful Closing of 4 98 Billion RMB Public Offering and Listing on the Shenzhen ChiNext Stock Exchange
news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.

Liangzhi xieSino biological inc augShenzhen stock exchangeSino biological incFrom sino biological inc augSino biologicalPrivate securities litigation reformShenzhen stockஷென்சென் ஸ்டாக் பரிமாற்றம்சினோ உயிரியல் இன்க்சினோ உயிரியல்ப்ரைவேட் பத்திரங்கள் வழக்கு சீர்திருத்தம்ஷென்சென் ஸ்டாக்

Qiming s Portfolio Company Sino Biological Lists on Shenzhen s ChiNext Market

Press release content from PR Newswire. The AP news staff was not involved in its creation.

United statesHong kongLiangzhi xieVenus medtechAmy tangCansino biologicsGan lee pharmaceuticalsWedoctor groupZai labShanghai stock exchangeShenzhen stock exchangeHorizon healthVenture partnerSino biologicalVenture partnersQiming venture

Sino Biological Announces Successful Closing of 4 98 Billion RMB Public Offering and Listing on the Shenzhen ChiNext Stock Exchange

BioPharma

Liangzhi xieShenzhen stock exchangeSino biological incSino biologicalPrivate securities litigation reformShenzhen stockஷென்சென் ஸ்டாக் பரிமாற்றம்சினோ உயிரியல் இன்க்சினோ உயிரியல்ப்ரைவேட் பத்திரங்கள் வழக்கு சீர்திருத்தம்ஷென்சென் ஸ்டாக்